Elon Musk's Neuralink is preparing to implant its FDA-approved Blindsight chip in the first human recipient this year. The breakthrough device aims to restore vision by directly stimulating the brain's visual cortex, potentially helping even those born blind or missing both eyes. Musk cautioned that initial vision quality would resemble "Atari graphics" but could eventually surpass natural vision, enabling perception of infrared and ultraviolet wavelengths. The Blindsight chip, which received FDA approval in September 2024, is part of Neuralink's broader mission to develop brain-computer interfaces for medical applications.